These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2300682)

  • 41. Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
    Piñeyro G; de Montigny C; Weiss M; Blier P
    Synapse; 1996 Jan; 22(1):54-62. PubMed ID: 8822478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
    Gleason SD; Shannon HE
    Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.
    Curzon G
    Adv Exp Med Biol; 1991; 294():377-88. PubMed ID: 1837683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release.
    Maura G; Raiteri M
    Eur J Pharmacol; 1986 Oct; 129(3):333-7. PubMed ID: 3780847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl)phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice.
    Przegaliński E; Baran L; Siwanowicz J
    Epilepsia; 1994; 35(4):889-94. PubMed ID: 8082639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes.
    Harel-Dupas C; Cloëz I; Fillion G
    J Neurochem; 1991 Jan; 56(1):221-7. PubMed ID: 1824781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The activation of serotonin receptors by tryptamine induces hyperinsulinemia in mice.
    Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K
    Eur J Pharmacol; 1990 Jun; 181(3):319-22. PubMed ID: 2200694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
    Smith BN; Sollars PJ; Dudek FE; Pickard GE
    J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripherally administered serotonin induces hyperglucagonemia in mice.
    Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K
    Life Sci; 1993; 52(23):1845-9. PubMed ID: 8502121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.
    Herremans AH; van der Heyden JA; van Drimmelen M; Olivier B
    Pharmacol Biochem Behav; 1999 Oct; 64(2):389-95. PubMed ID: 10515319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-HT1A and 5-HT1B agonists play a differential role on the respiratory frequency in rats.
    Edwards E; Whitaker-Azmitia PM; Harkins K
    Neuropsychopharmacology; 1990 Apr; 3(2):129-36. PubMed ID: 2138459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-HT1-like receptor agonists enhance wakefulness.
    Dzoljic MR; Ukponmwan OE; Saxena PR
    Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors.
    Kalkman HO
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):583-4. PubMed ID: 8751090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of tricyclic antidepressant drugs in the isolation-induced social behavioural deficit test.
    Frances H; Danti S; Fermanian J
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):229-35. PubMed ID: 2748863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
    Pranzatelli MR; Tailor PT
    Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New animal model of social behavioral deficit: reversal by drugs.
    Francès H
    Pharmacol Biochem Behav; 1988 Mar; 29(3):467-70. PubMed ID: 3362939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants.
    Green AR; Guy AP; Gardner CR
    Neuropharmacology; 1984 Jun; 23(6):655-61. PubMed ID: 6462374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.